Director Third Party Excellence

Site Name: GSK HQ, Bangalore, Belgium-Wavre, Canada - Ontario - Mississauga, UK - Hertfordshire - Stevenage, USA - Pennsylvania - Upper Providence, Warsaw

Posted Date: Jan 6 2026

At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the immune system with cutting‑edge technology to transform people’s lives. GSK fosters a culture ambitious for patients, accountable for impact, and committed to doing the right thing, making sure that we focus our efforts on accelerating significant assets that meet patients’ needs and have the highest probability of success.

We’re uniting science, technology, and talent to get ahead of disease together.

The Director, Third Party Excellence is responsible for ensuring successful delivery of GSK’s clinical studies by establishing and sustaining strong governance and strategic relationships with third‑party providers. This role drives compliance with contractual and regulatory requirements, oversees portfolio‑level performance against expectations, proactively identifies and mitigates risks and issues, and seeks opportunities to improve third‑party performance. The TP Director leads a multidisciplinary, cross‑functional oversight team in a matrix environment, partnering closely with functional and business stakeholders.

• Governance of key third parties delivering services across multiple functions; lead end‑to‑end operational and strategic governance, ensuring appropriate oversight activities and measures.
• Provide guidance and support to others involved to ensure optimal execution.
• Serve as the primary contact within Global Clinical Operations (GCO) and affiliated clinical development functions for TP‑level strategic relationships, focusing on improving performance through effective relationship management.
• Oversee cross‑Therapeutic Area Full‑Service‑Provider (FSO) third‑party oversight, collaborating closely with the Research Unit Third Party Management Directors.
• Drive efficient and effective governance forums where clear outputs and decisions are made and reviews focus on improving and accelerating performance, optimizing opportunities, and mitigating risks.
• Collaborate with and across functions and business areas to translate information into key insights, proactively identify major risks and opportunities, and drive strategies and actions accordingly.
• Senior point of escalation; lead and facilitate discussions involving appropriate internal and external stakeholders to accelerate resolution, inform decisions and/or remove blockers.
• Conduct internal and external operational cross‑portfolio reviews, providing partnership updates, gathering team feedback on performance and resources, and assessing risks.
• Accountable for the full portfolio of services delivered by assigned Third Parties for clinical studies, ensuring timely execution and adherence to MSA, SLA, and QAg.
• Establish TP partnership KPIs through cross‑functional collaboration with business partners and TP; review and discuss KPIs, KQIs, and KFIs with third parties, analyze trends, and propose strategies and mitigations.
• Ensure appropriate documentation is in place for oversight, governance, risk management, issue resolution, and strategic discussions to ensure audit readiness.
• Ensure robust oversight of Third Parties is in place with accountability for the oversight at the cross‑service level.
• May contribute to functional and cross‑functional initiatives and improvement projects.

• Bachelor’s degree or equivalent in a relevant field.
• Prior Management and oversight of cross‑functional FSO or FSP providers delivering services (must include clinical operations).
• Experience of late‑phase Global Clinical Trial Management or Study Management in a pharmaceutical company or CRO.
• Proven experience in third‑party management, vendor management, procurement or contracting.
• Experience working in a regulated environment within pharmaceuticals, biotech, or healthcare.
• Strong stakeholder management and…